10.495 Molecular Design and Bioprocess Development of Immunotherapies


Class Info

Examines challenges and opportunities for applying chemical engineering principles to address the growing global burden of infectious disease, including drug-resistant strains and neglected pathogens. Topics include a historical overview of vaccines and immunotherapies, the molecular design considerations for new immunotherapies and adjuvants, the economic challenges for process development and manufacturing of immunotherapies, and new technologies for designing and assessing therapies. Case studies to cover topics for specific diseases. Students taking graduate version complete additional assignments.

This class has 7.06 as a prerequisite.

10.495 will be offered this semester (Spring 2017). It is instructed by J. C. Love.

This class counts for a total of 9 credits.

In the Spring 2011 Subject Evaluations, 10.495 was rated 6.8 out of 7.0. You can find more information at the 10.495 Class Site site or on the 10.495 Stellar site.

MIT 10.495 Molecular Design and Bioprocess Development of Immunotherapies Related Textbooks
MIT 10.495 Molecular Design and Bioprocess Development of Immunotherapies On The Web

© Copyright 2015